Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study Of Gemcitabine Versus Gemcitabine-Oxaliplatine In Patients With Locally Advanced Or Metastatic Pancreatic Carcinoma

NCT00075452 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT00075452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00075452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study Of Gemcitabine Versus Gemcitabine-Oxaliplatine In Patients With Locally Advanced Or Metastatic Pancreatic Carcinoma
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2003
Completion date
Not reported
Enrollment
Not reported
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer